Prevail Therapeutics Inc
- Fund Information and Directors
| Prevail Therapeutics Inc |
| Firm |
|
| Fund # | |
| CIK # | 0001714798 |
| Sale | 2018-03-07
($65.0 M Offered, $57.0 M Sold)
|
| Fund | |
| Phone | 9173369310 |
| Address | 430 East 29th Street, Suite 940
New York, New York 10016 |
| Source |
[EDGAR]
|
| Fund AUM and Sold ($M) |
|
|
| Fund Details |
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction | |
| Form D Offering |
| Filed | 2018-03-14 (D) |
| Exemption | 506(b) |
| Remaining | $8,000,010 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 212700535, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
316417464